| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| CONCOR 5 mg | BISOPROLOLUM | COMPR. FILM. | C07AB07 | W66285001 | MERCK ROMANIA SRL - ROMANIA | ||||||
| CONCOR 5 mg | BISOPROLOLUM | COMPR. FILM. | C07AB07 | W66285002 | MERCK ROMANIA SRL - ROMANIA | ||||||
| CONCOR 10 mg | BISOPROLOLUM | COMPR. FILM. | C07AB07 | W66286001 | MERCK ROMANIA SRL - ROMANIA | ||||||
| CONCOR 10 mg | BISOPROLOLUM | COMPR. FILM. | C07AB07 | W66286002 | MERCK ROMANIA SRL - ROMANIA | ||||||
| CONCERTA 54 mg | METHYLFENIDATUM | COMPR. CU ELIB. PREL. | N06BA04 | W70641001 | JANSSEN-CILAG INTERNATIONAL N.V. - BELGIA | ||||||
| CONCERTA 54 mg | METHYLFENIDATUM | COMPR. CU ELIB. PREL. | N06BA04 | W70641002 | JANSSEN-CILAG INTERNATIONAL N.V. - BELGIA | ||||||
| CONCERTA 36 mg | METHYLFENIDATUM | COMPR. CU ELIB. PREL. | N06BA04 | W70640001 | JANSSEN-CILAG INTERNATIONAL N.V. - BELGIA | ||||||
| CONCERTA 36 mg | METHYLFENIDATUM | COMPR. CU ELIB. PREL. | N06BA04 | W70640002 | JANSSEN-CILAG INTERNATIONAL N.V. - BELGIA | ||||||
| CONCERTA 18 mg | METHYLFENIDATUM | COMPR. CU ELIB. PREL. | N06BA04 | W70639001 | JANSSEN-CILAG INTERNATIONAL N.V. - BELGIA | ||||||
| CONCERTA 18 mg | METHYLFENIDATUM | COMPR. CU ELIB. PREL. | N06BA04 | W70639002 | JANSSEN-CILAG INTERNATIONAL N.V. - BELGIA | ||||||
| COMTESS 200mg | ENTACAPONUM | COMPR. FILM. | N04BX02 | W51543001 | ORION CORPORATION - FINLANDA | X | |||||
| COMTESS 200mg | ENTACAPONUM | COMPR. FILM. | N04BX02 | W51543002 | ORION CORPORATION - FINLANDA | X | |||||
| COMTESS 200mg | ENTACAPONUM | COMPR. FILM. | N04BX02 | W51543003 | ORION CORPORATION - FINLANDA | X | |||||
| COMTESS 200mg | ENTACAPONUM | COMPR. FILM. | N04BX02 | W51543004 | ORION CORPORATION - FINLANDA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.4-5 dispersie injectabila | TOZINAMERAN/FAMTOZINAMERAN vacc.tipARNmCOVID-19(cu nucleozide modificate) | DISPERSIE INJECTABILA | J07BX03 | W69195001 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.4-5 dispersie injectabila | TOZINAMERAN/FAMTOZINAMERAN vacc.tipARNmCOVID-19(cu nucleozide modificate) | DISPERSIE INJECTABILA | J07BX03 | W69195002 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.4-5 concentrat pentru dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | CONC. PT. DISPERSIE INJECTABILA | J07BX03 | W69311001 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.4-5 concentrat pentru dispersie injectabila | TOZINAMERAN, vacc.tipARNmCOVID-19(cu nucleozide modificate) | CONC. PT. DISPERSIE INJECTABILA | J07BX03 | W69311002 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.1 dispersie injectabila | TOZINAMERAN/RILTOZINAMERAN vacc.tipARNmCOVID-19(cu nucleozide modificate) | DISPERSIE INJECTABILA | J07BX03 | W69194001 | BIONTECH MANUFACTURING GMBH - GERMANIA | X | |||||
| COMIRNATY ORIGINAL/OMICRON BA.1 dispersie injectabila | TOZINAMERAN/RILTOZINAMERAN vacc.tipARNmCOVID-19(cu nucleozide modificate) | DISPERSIE INJECTABILA | J07BX03 | W69194002 | BIONTECH MANUFACTURING GMBH - GERMANIA | X |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman